» Articles » PMID: 35394619

Single-Cell Transcriptome Analysis Reveals the Role of Pancreatic Secretome in COVID-19 Associated Multi-organ Dysfunctions

Overview
Journal Interdiscip Sci
Specialty Biology
Date 2022 Apr 8
PMID 35394619
Authors
Affiliations
Soon will be listed here.
Abstract

The SARS-CoV-2 infection affects the lungs, heart, kidney, intestine, olfactory epithelia, liver, and pancreas and brings forward multi-organ dysfunctions (MODs). However, mechanistic details of SARS-CoV-2-induced MODs are unclear. Here, we have investigated the role of pancreatic secretory proteins to mechanistically link COVID-19 with MODs using single-cell transcriptome analysis. Secretory proteins were identified using the Human Protein Atlas. Gene ontology, pathway, and disease enrichment analyses were used to highlight the role of upregulated pancreatic secretory proteins (secretome). We show that SARS-CoV-2 infection shifts the expression profile of pancreatic endocrine cells to acinar and ductal cell-specific profiles, resulting in increased expression of acinar and ductal cell-specific genes. Among all the secretory proteins, the upregulated expression of IL1B, AGT, ALB, SPP1, CRP, SERPINA1, C3, TFRC, TNFSF10, and MIF was mainly associated with disease of diverse organs. Extensive literature and experimental evidence are used to validate the association of the upregulated pancreatic secretome with the coagulation cascade, complement activation, renin-angiotensinogen system dysregulation, endothelial cell injury and thrombosis, immune system dysregulation, and fibrosis. Our finding suggests the influence of an upregulated secretome on multi-organ systems such as nervous, cardiovascular, immune, digestive, and urogenital systems. Our study provides evidence that an upregulated pancreatic secretome is a possible cause of SARS-CoV-2-induced MODs. This finding may have a significant impact on the clinical setting regarding the prevention of SARS-CoV-2-induced MODs.

Citing Articles

Identification and evaluation of candidate COVID-19 critical genes and medicinal drugs related to plasma cells.

Liu Z, Petinrin O, Chen N, Toseef M, Liu F, Zhu Z BMC Infect Dis. 2024; 24(1):1099.

PMID: 39363208 PMC: 11451256. DOI: 10.1186/s12879-024-10000-3.


Integration of Omics Data and Network Models to Unveil Negative Aspects of SARS-CoV-2, from Pathogenic Mechanisms to Drug Repurposing.

Bernardo L, Lomagno A, Mauri P, Silvestre D Biology (Basel). 2023; 12(9).

PMID: 37759595 PMC: 10525644. DOI: 10.3390/biology12091196.


Computational exploration of the dual role of the phytochemical fortunellin: Antiviral activities against SARS-CoV-2 and immunomodulatory abilities against the host.

Agrawal S, Pathak E, Mishra R, Mishra V, Parveen A, Mishra S Comput Biol Med. 2022; 149:106049.

PMID: 36103744 PMC: 9452420. DOI: 10.1016/j.compbiomed.2022.106049.

References
1.
Fang L, Karakiulakis G, Roth M . Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?. Lancet Respir Med. 2020; 8(4):e21. PMC: 7118626. DOI: 10.1016/S2213-2600(20)30116-8. View

2.
Giacomelli A, Pezzati L, Conti F, Bernacchia D, Siano M, Oreni L . Self-reported Olfactory and Taste Disorders in Patients With Severe Acute Respiratory Coronavirus 2 Infection: A Cross-sectional Study. Clin Infect Dis. 2020; 71(15):889-890. PMC: 7184514. DOI: 10.1093/cid/ciaa330. View

3.
Lamers M, Beumer J, van der Vaart J, Knoops K, Puschhof J, Breugem T . SARS-CoV-2 productively infects human gut enterocytes. Science. 2020; 369(6499):50-54. PMC: 7199907. DOI: 10.1126/science.abc1669. View

4.
Puelles V, Lutgehetmann M, Lindenmeyer M, Sperhake J, Wong M, Allweiss L . Multiorgan and Renal Tropism of SARS-CoV-2. N Engl J Med. 2020; 383(6):590-592. PMC: 7240771. DOI: 10.1056/NEJMc2011400. View

5.
Peiris S, Mesa H, Aysola A, Manivel J, Toledo J, Borges-Sa M . Pathological findings in organs and tissues of patients with COVID-19: A systematic review. PLoS One. 2021; 16(4):e0250708. PMC: 8081217. DOI: 10.1371/journal.pone.0250708. View